VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,656,746 | +3.6% | 47,900 | +4.8% | 0.02% | 0.0% |
| Q2 2023 | $16,082,287 | +18.7% | 45,700 | +6.3% | 0.02% | -6.2% |
| Q1 2023 | $13,548,010 | +11.2% | 43,000 | +1.9% | 0.02% | -15.8% |
| Q4 2022 | $12,186,516 | +43.2% | 42,200 | +43.5% | 0.02% | +72.7% |
| Q3 2022 | $8,512,000 | +79.2% | 29,400 | +61.5% | 0.01% | +120.0% |
| Q1 2022 | $4,750,000 | +89.6% | 18,200 | +71.7% | 0.01% | +66.7% |
| Q4 2020 | $2,505,000 | +243.6% | 10,600 | +140.9% | 0.00% | +50.0% |
| Q4 2018 | $729,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 86,000 | $14,617,000 | 0.12% |
| SIMPLEX TRADING, LLC | 572 | $9,721,000 | 0.04% |
| JPMORGAN CHASE & CO | 66,600 | $11,319,000 | 0.00% |
| Allianz Asset Management GmbH | 3,900 | $663,000 | 0.00% |